Matti Kivikko

R&d
Espoo, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Levosimendan as an Antidote in Experimental Calcium Channel Blocker Intoxication.

Levosimendan as an Antidote in Experimental Calcium Channel Blocker Intoxication.

Journal: Journal of cardiovascular pharmacology

Published: May 08, 2024

Renal Impairment in Patients With Acute Heart Failure: Are Inotropes Safe?

Renal Impairment in Patients With Acute Heart Failure: Are Inotropes Safe?

Journal: Journal of cardiovascular pharmacology

Published: April 06, 2022

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.

Journal: Journal of cardiovascular pharmacology

Published: July 09, 2020

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.

Journal: Cardiac failure review

Published: February 06, 2020

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.

Journal: International journal of cardiology

Published: May 15, 2019

Repetitive levosimendan treatment in the management of advanced heart failure.

Repetitive levosimendan treatment in the management of advanced heart failure.

Journal: European heart journal supplements : journal of the European Society of Cardiology

Published: December 18, 2018

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.

Journal: Cardiovascular drugs and therapy

Published: November 08, 2018

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice.

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice.

Journal: Journal of cardiovascular pharmacology

Published: October 28, 2017

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications.

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications.

Journal: Journal of cardiovascular pharmacology

Published: August 18, 2017

Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.

Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.

Journal: International journal of cardiology

Published: February 16, 2017

Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.

Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.

Journal: International journal of cardiology

Published: May 25, 2016

The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.

The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.

Journal: International journal of cardiology

Published: March 31, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026